Symmetry Partners’s Eastman Chemical EMN Stock Holding History

Symmetry Partners’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,459	Closed	-$246K	–	524
2024 Q1	$246K	Hold	2,459	–	–	0.02%	482
2023 Q4	$222K	Buy	+2,459	New	+$196K	0.01%	469
2023 Q3	–	Sell	-2,459	Closed	-$206K	–	543
2023 Q2	$206K	Hold	2,459	–	–	0.01%	558
2023 Q1	$207K	Hold	2,459	–	–	0.01%	536
2022 Q4	$200K	Buy	+2,459	New	+$198K	0.01%	536
2022 Q3	–	Sell	-8,609	Closed	-$773K	–	554
2022 Q2	$773K	Hold	8,609	–	–	0.05%	221
2022 Q1	$965K	Hold	8,609	–	–	0.06%	202
2021 Q4	$1.04M	Sell	8,609 -1,328	-13%	-$148K	0.07%	200
2021 Q3	$1.04M	Hold	9,937	–	–	0.07%	209
2021 Q2	$1.16M	Buy	9,937 +359	+4%	+$43.1K	0.08%	193
2021 Q1	$1.05M	Hold	9,578	–	–	0.08%	188
2020 Q4	$960K	Buy	9,578 +1,043	+12%	+$96.7K	0.07%	192
2020 Q3	$667K	Buy	+8,535	New	+$643K	0.06%	247
2019 Q2	–	Sell	-2,108	Closed	-$160K	–	356
2019 Q1	$160K	Hold	2,108	–	–	0.03%	339
2018 Q4	$154K	Buy	+2,108	New	+$168K	0.04%	289

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Symmetry Partners's EMN Position: Q2 2024 in Review

Symmetry Partners sold out of Eastman Chemical (EMN) in Q2 2024, closing a stake of 2,459 shares — an estimated $246K sold.

Symmetry Partners first reported a position in EMN in Q4 2018 and held it in 15 quarters. The position peaked at $1.16M in Q2 2021. 752 funds tracked by Wall St. Rank hold EMN as of Q2 2024.

Symmetry Partners reported no remaining Eastman Chemical position as of Q2 2024 after selling out during the quarter.
Symmetry Partners sold 2,459 Eastman Chemical shares in Q2 2024, an estimated $246K.
Symmetry Partners first reported a position in Eastman Chemical in Q4 2018 and held it in 15 quarters.
Symmetry Partners's Eastman Chemical position peaked at $1.16M in Q2 2021.
752 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2024.

Based on Symmetry Partners's 13F filing for Q2 2024, filed 11 Jul 2024.